La sclérose en plaques en 2007
FROMONT A. ET AL.
Kinésithér Scient 2007,482:23-29 - 10/11/2007
La sclérose en plaques (SEP) est une maladie inflammatoire du système nerveux central caractérisée par deux événements : la poussée et la progression. Leur combinaison permet de définir trois profils évolutifs : les formes récurrentes rémittentes, les formes secondairement progressives et les formes progressives d'emblée. Ces formes évolutives sont importantes à connaître car elles conditionnent les indications thérapeutiques.
Le pronostic de la SEP va des formes dites benignes" aux formes rapidement invalidantes.
Multiple sclerosis in 2007
Multiple sclerosis is an inflammatory disease of the central nervous system characterised by two aspects: the outbreak and the progression. their combination is used to define three profiles that follow specific stages of development: the recurrent remittent forms, the secondarily progressive forms and the progressive forms from the onset. it is important to be familiar with these evolving forms since they condition the therapeutic indications.
The prognosis of multiple sclerosis ranges from the so-called "benign" forms to the rapidly invalidating forms."
Le pronostic de la SEP va des formes dites benignes" aux formes rapidement invalidantes.
Multiple sclerosis in 2007
Multiple sclerosis is an inflammatory disease of the central nervous system characterised by two aspects: the outbreak and the progression. their combination is used to define three profiles that follow specific stages of development: the recurrent remittent forms, the secondarily progressive forms and the progressive forms from the onset. it is important to be familiar with these evolving forms since they condition the therapeutic indications.
The prognosis of multiple sclerosis ranges from the so-called "benign" forms to the rapidly invalidating forms."
